ICON in the black

ISEQ listed medical technology company ICON today announced that it now expects its Central Lab business unit return to profit in the second quarter ending June 30.

“We are very pleased that strong revenue growth in the lab, supported by excellent new business wins, has accelerated our return to profitability in this unit. Our core clinical business continues to perform in line with plans,” said CEO Mr Peter Gray.